| MAPK11 |
MAPK11, PRKM11, SAPK2: Mitogen-activated protein kinase 11 |
SSH2 |
SSH2, KIAA1725, SSH2L: Protein phosphatase Slingshot homolog 2 |
0.535 |
Evidence |
|
| TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
NFKB2 |
IPI00477537 |
0.535 |
Evidence |
|
| TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.535 |
Evidence |
|
| EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| PTGES3 |
PTGES3, P23, TEBP: Prostaglandin E synthase 3 |
CRYBA4 |
CRYBA4: Beta-crystallin A4 |
0.535 |
Evidence |
|
| PEA15 |
PEA15: Astrocytic phosphoprotein PEA-15 |
NFKB2 |
IPI00477537 |
0.535 |
Evidence |
|
| STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
NTRK2 |
NTRK2, TRKB: BDNF/NT-3 growth factors receptor precursor |
0.535 |
Evidence |
|
| PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.535 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
FLT4 |
VEGFR3 long form |
0.535 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.535 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
NTRK2 |
NTRK2, TRKB: BDNF/NT-3 growth factors receptor precursor |
0.535 |
Evidence |
|
| RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
NFKB2 |
IPI00477537 |
0.535 |
Evidence |
|
| GRB10 |
IPI00012752 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.535 |
Evidence |
|
| GRB10 |
IPI00012752 |
JAK1 |
|
0.535 |
Evidence |
|
| GRB10 |
IPI00012752 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.535 |
Evidence |
|
| GRB10 |
IPI00012752 |
FLT4 |
VEGFR3 long form |
0.535 |
Evidence |
|
| GRB10 |
IPI00012752 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.535 |
Evidence |
|
| GRB10 |
IPI00012752 |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.535 |
Evidence |
|
| GRB10 |
IPI00012752 |
NTRK2 |
NTRK2, TRKB: BDNF/NT-3 growth factors receptor precursor |
0.535 |
Evidence |
|
| GRB10 |
IPI00012752 |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
0.535 |
Evidence |
|
| GRB10 |
IPI00012752 |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
0.535 |
Evidence |
|
| GRB10 |
IPI00012752 |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
0.535 |
Evidence |
|